TipRanks
Eastman Chemical (MX:EMN)
:EMN
Mexico Market
EarningsQ2 2026 Earnings Report

Eastman Chemical (EMN) Q2 2026 Earnings Report

0 Followers

MX:EMN Q2 2026 EPS Results

Actual EPS$35.78
Consensus EPS$33.05
Beat/MissBeat by +$2.72
One Year Ago EPS$29.06

MX:EMN Q2 2026 Revenue Results

Actual Revenue$45.69B
Expected Revenue$43.54B
Beat/MissBeat by +$2.15B
YoY Revenue Growth+9.82%

Earnings Announcement Details

QuarterQ2 2026
Date07/30/2026
TimeAfter Close
Conference CallThursday, July 30, 2026
MX:EMN Upcoming Earnings
Eastman Chemical's next earnings date is estimated for October 22, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

MX:EMN Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Jul 30, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed several substantive operational and commercial wins — a Q2 beat, strong pricing actions (~$500M revenue uplift from pricing), Renew/circular revenue momentum (> $100M YTD, ~100% growth vs. prior year), solid methanolysis technical performance (yields >90%) and ongoing cost reduction execution — which collectively point to improving earnings momentum into the back half of the year. Offsetting these positives are persistent weak discretionary end markets, textile/Fibers pressure, receivables-driven cash use (~$370M), some capacity constraints that modestly reduced near-term revenue guidance, and uncertainty around Chemical Intermediates spreads tied to Middle East dynamics. On balance the company presented more actionable positives and clear mitigation plans than outsized negatives, though several macro and inventory/market risks remain.
Company Guidance
Management said the outlook is better than in April after a strong Q2 and expects a stronger back half: Advanced Materials volumes grew ~5% in Q2 and are expected to be flat sequential into Q3 but substantially higher year‑over‑year, Renew sales increased by >$100M in H1 (roughly double vs. prior year) and roughly half of AM’s growth, and Q4 should be the strongest quarter for Kingsport methanolysis (about $100M this year, annualizing into 2027). Key operational metrics cited include methanolysis yields >90%, ~30% debottleneck potential at Kingsport, polymer capacity target up to ~130,000 tonnes (~130% of design), and prior Renew asset utilization of ~50% with room to reach 100%. Financial drivers and guidance items: pricing actions are expected to add roughly $500M of revenue this year, a cost‑reduction program of $125–150M (net of inflation), a Q2 turnaround headwind of ~$40–45M (now expected to swing to a ~$10–20M sequential benefit vs. the original plan), YTD receivables use of ~$370M and a working‑capital target moving from about $970M toward ~$900M (~$75M improvement), plus management remains on track for the Renew platform’s first‑asset target of ~$200M EBITDA — while noting Chemical Intermediates spreads are uncertain given Middle East dynamics.
Q2 Beat and Positive Back-Half Outlook
Management described a 'strong beat' in Q2 with confidence in a solid Q3 and a stronger back half; Q4 is expected to be the strongest revenue quarter of the year.
Advanced Materials Volume Growth
Advanced Materials reported ~5% volume growth in Q2, with volumes expected to be flat sequentially into Q3 (but substantially higher year-over-year) supported by wins and utilization tailwinds.
Renew / Circular Platform Acceleration
Circular (Renew) revenue grew by more than $100 million year-to-date — roughly double vs. last year (~100% increase) — and represents about half of Advanced Materials' segment growth; management remains on track for long-term asset targets (first asset pathway to $200 million EBITDA) though timing may extend.
Strong Pricing / Price-Cost Management
Company executed disciplined price increases that management estimates will drive roughly $500 million of incremental revenue this year from pricing actions, producing a price/cost tailwind into the second half and keeping variable margin per kg relatively stable versus 2019 levels.
Additives & Functional Products Margin Resilience
AFP delivered resilient margins despite weak end markets — ~2/3 of AFP revenue is from stable end markets (pharma, water treatment, ag, personal care, aviation) and the business benefits from cost pass-through contracts and strong competitive positions.
Methanolysis / Kingsport Operational Strength
Kingsport methanolysis plant running with yields above 90%; management can debottleneck the plant by ~30% to increase throughput, has increased utilization from ~50% and believes it can operate to 100% and ultimately target ~130% of original design with incremental capital; larger capital spend timing deferred to ~2028 to align with market recovery.
Cost Reduction and Working Capital Progress
Company remains on track for $125–$150 million net cost reductions (net of inflation); management expects to move working capital down toward ~$900 million (from ~$970 million), implying roughly a $75 million improvement versus prior levels.
Innovation and Market Wins
Strong specialty innovation momentum — management cited mid-teens to ~20% of specialty sales from new products, product wins across Tritan, performance films (China), new cosmetic recycled products, and semiconductor solvents — driving specialty revenue growth and mix uplift.

MX:EMN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Oct 22, 2026
2026 (Q3)
35.34 / -
20.703―
2026 (Q2)
33.05 / 35.78
29.05723.12% (+6.72)
2026 (Q1)
19.32 / 19.80
34.687-42.93% (-14.89)
2025 (Q4)
13.08 / 13.62
33.96-59.89% (-20.34)
2025 (Q3)
21.03 / 20.70
41.043-49.56% (-20.34)
2025 (Q2)
31.38 / 29.06
39.045-25.58% (-9.99)
2025 (Q1)
34.36 / 34.69
29.23918.63% (+5.45)
2024 (Q4)
28.58 / 33.96
23.7942.75% (+10.17)
2024 (Q3)
39.06 / 41.04
26.69653.74% (+14.35)
2024 (Q2)
36.54 / 39.05
36.148.04% (+2.91)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed